SCHEMBL720619

SCHEMBL720619

Nc1ccc(-c2nnc(-c3cccs3)o2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 17/20 0.71
NPC1 O15118 15/20 0.71
KDM4E B2RXH2 15/20 0.71
ALDH1A1 P00352 15/20 0.71
SMN1; SMN2 Q16637 12/20 0.71
NFKB1 P19838 3/20 0.71
NFKB2 Q00653 3/20 0.71
RELA Q04206 3/20 0.71
ATAD2 Q6PL18 1/20 0.70
MAPT P10636 5/20 0.66
MEN1 O00255 2/20 0.66
KMT2A Q03164 2/20 0.66
GAA P10253 2/20 0.66
HCRTR1 O43613 1/20 0.66
CASP3 P42574 1/20 0.66
SENP7 Q9BQF6 1/20 0.66
RXFP1 Q9HBX9 1/20 0.66
HPGD P15428 11/20 0.61
HSD17B10 Q99714 10/20 0.59
TP53 P04637 6/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7059841 0.84 ALDH1A1 (0.73) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL13762461 0.84 KDM4E (0.70) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL13930785 0.83 ALDH1A1 (1.00) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL13930781 0.83 ALDH1A1 (0.71) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL3263307 0.83 KDM4E (0.71) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL16771498 0.83 ATAD2 (1.00) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL29454512 0.83 ATAD2 (1.00) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL13930783 0.81 KDM4E (0.68) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL22471879 0.80 ATAD2 (0.61) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL601473 0.80 NPC1 (1.00) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8618145-B2 Small molecular compounds capable of accelerating proliferation of stem cells and use thereof HAN MEI (CN) 2013-12-31 US disclosed
US-20120053214-A1 THE LITTLE MOLECULE COMPOUND WHICH USED FOR PROMOTING THE STEM CELLS HYPERPLASIA AND THE USE THEREOF HAN MEI (CN) 2012-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120053214-A1 THE LITTLE MOLECULE COMPOUND WHICH USED FOR PROMOTING THE STEM CELLS HYPERPLASIA AND THE USE THEREOF MKI67, KIT, PCNA RAB9A 2617/4885NPC1 2926/4885KDM4E 3239/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.